Kinase mutations in human disease: interpreting genotype–phenotype relationships

The protein kinase complement of the human genome

Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145

Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases

Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295

The MAPK signaling cascade

Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,631

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548

The druggable genome

Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272

A census of human cancer genes

Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184

Patterns of somatic mutation in human cancer genomes

Greenman, C. D., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G. R., Davies, H. R., Teague, J. W., Butler, A. P., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,143

Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification

Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104

Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF

Wan, P., Garnett, M. J., Roe, S. M., Lee, S., Niculescu‐Duvaz, D., Good, V. M., Cancer Genome Project, Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,863

The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

Hanks, S. K., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768349 · Cited by 2,828

Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.

Hanks, S. K., & Hunter, T. R. (1995) · PubMed · Cited by 2,518

Regulation of neuronal survival by the serine-threonine protein kinase Akt

Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436

Genome-wide association study identifies novel breast cancer susceptibility loci

Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., Struewing, J. P., Morrison, J., Field, H., Luben, R., et al. (2007) · Nature · doi:10.1038/nature05887 · Cited by 2,319

Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes

Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

Mulligan, L. M., Kwok, J. B., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,956

Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)

Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,860

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

Tartaglia, M., Mehler, E. L., Goldberg, R. B., Zampino, G., Brunner, H. G., Kremer, H., van der Burgt, I., Crosby, A. H., Ion, A., Jeffery, S., et al. (2001) · Nature Genetics · doi:10.1038/ng772 · Cited by 1,736

A Common Allele on Chromosome 9 Associated with Coronary Heart Disease

McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg-Hansen, A., Folsom, A. R., et al. (2007) · Science · doi:10.1126/science.1142447 · Cited by 1,587

PROTEIN SERINE/THREONINE KINASES

Edelman, A. M., Blumenthal, D., & Krebs, E. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003031 · Cited by 1,435

Identification of ALK as a major familial neuroblastoma predisposition gene

Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia

Shiang, R., Thompson, L. M., Zhu, Y., Church, D. M., Fielder, T. J., Bocian, M. E., Winokur, S. T., & Wasmuth, J. J. (1994) · Cell · doi:10.1016/0092-8674(94)90302-6 · Cited by 1,329

BRAF mutation predicts sensitivity to MEK inhibition

Solit, D. B., Garraway, L. A., Pratilas, C. A., Sawai, A., Getz, G. A., Basso, A., Ye, Q., Lobo, J. M., She, Y., Osman, I., et al. (2005) · Nature · doi:10.1038/nature04304 · Cited by 1,326

Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci

The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

Shore, E. M., Xu, M., Feldman, G. J., Fenstermacher, D., Cho, T., Choi, I. H., Connor, J. M., Delai, P. L. R., Glaser, D. L., Merrer, M. F. L., et al. (2006) · Nature Genetics · doi:10.1038/ng1783 · Cited by 1,215

Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex

Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Baxter, E. J., SCOTT, L., Campbell, P. J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74230-6 · Cited by 1,141

Multiple, Distinct Forms of Bovine and Human Protein Kinase C Suggest Diversity in Cellular Signaling Pathways

Coussens, L. M., Parker, P. J., Rhee, L. M., Yang‐Feng, T. L., Chen, E., Waterfield, M. D., Francke, U., & Ullrich, A. (1986) · Science · doi:10.1126/science.3755548 · Cited by 1,042

Evolution of protein kinase signaling from yeast to man

Manning, G., Plowman, G. D., Hunter, T. R., & Sudarsanam, S. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02179-5 · Cited by 1,004

Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome

Wilkie, A. O. M., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-165 · Cited by 935

Oncogenic mutations of ALK kinase in neuroblastoma

Chen, Y., Takita, J., Choi, Y. L., Kato, M., Ohira, M., Sanada, M., Wang, L., Soda, M., Kikuchi, A., Igarashi, T., et al. (2008) · Nature · doi:10.1038/nature07399 · Cited by 930

The Catalogue of Somatic Mutations in Cancer (COSMIC)

Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C. Y., Clements, J., Menzies, A. H., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 899

On target with a new mechanism for the regulation of protein phosphorylation

Hubbard, M. J., & Cohen, P. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90109-z · Cited by 896

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Janoueix‐Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 893

Activating mutations in ALK provide a therapeutic target in neuroblastoma

George, R. E., Sanda, T., Hanna, M., Fröhling, S., II, W. L., Zhang, J., Ahn, Y., Zhou, W., London, W. B., McGrady, P., et al. (2008) · Nature · doi:10.1038/nature07397 · Cited by 893

A TEL-JAK2 Fusion Protein with Constitutive Kinase Activity in Human Leukemia

Penard‐Lacronique, V., Boureux, A., Della-Valle, V., Poirel, H. A., Quang, C. T., Mauchauffé, M., Berthou, C., Lessard, M., Berger, R., Ghysdael, J., et al. (1997) · Science · doi:10.1126/science.278.5341.1309 · Cited by 796

Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome

Reardon, W., Winter, R., Rutland, P., Pulleyn, L., Jones, B., & Malcolm, S. (1994) · Nature Genetics · doi:10.1038/ng0994-98 · Cited by 746

Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions

Winkelmann, J., Schormair, B., Lichtner, P., Ripke, S., Xiong, L., Jalilzadeh, S., Fulda, S., Pütz, B., Eckstein, G., Hauk, S., et al. (2007) · Nature Genetics · doi:10.1038/ng2099 · Cited by 706

BMP type I receptor inhibition reduces heterotopic ossification

Yu, P. B., Deng, D. Y., Lai, C. S. C., Hong, C. C., Cuny, G. D., Bouxsein, M., Hong, D. W., McManus, P. M., Katagiri, T., Sachidanandan, C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1888 · Cited by 641

A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome

Muenke, M., Schell, U., Hehr, A., Robin, N. H., Losken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-269 · Cited by 614

Colocalization of X-Linked Agammaglobulinemia and X-Linked Immunodeficiency Genes

Thomas, J. D., Sideras, P., Smith, C. I. E., Vořechovský, I., Chapman, V. M., & Paul, W. E. (1993) · Science · doi:10.1126/science.8332900 · Cited by 613

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3

Tavormina, P. L., Shiang, R., Thompson, L. M., Zhu, Y., Wilkin, D. J., Lachman, R. S., Wilcox, W. R., Rimoin, D. L., Cohn, D. H., & Wasmuth, J. J. (1995) · Nature Genetics · doi:10.1038/ng0395-321 · Cited by 602

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

Niihori, T., Aoki, Y., Narumi, Y., Neri, G., Cavé, H., Verloès, A., Okamoto, N., Hennekam, R. C. M., Gillessen‐Kaesbach, G., Wieczorek, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1749 · Cited by 597

Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome

Rodriguez‐Viciana, P., Tetsu, O., Tidyman, W. E., Estep, A. L., Conger, B. A., Cruz, M. S., McCormick, F. P., & Rauen, K. A. (2006) · Science · doi:10.1126/science.1124642 · Cited by 569

A Family with Severe Insulin Resistance and Diabetes Due to a Mutation in AKT2

George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., Soos, M. A., Murgatroyd, P. R., Williams, R. M., Acerini, C. L., et al. (2004) · Science · doi:10.1126/science.1096706 · Cited by 562

Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

The Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) · Nature Genetics · doi:10.1038/ng.396 · Cited by 550

Craniosynostosis: genes and mechanisms

Wilkie, A. O. M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.10.1647 · Cited by 528

A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO)

Zonana, J., Elder, M. E., Schneider, L. C., Orlow, S. J., Moss, C., Golabi, M., Shapira, S. K., Farndon, P. A., Wara, D. W., Emmal, S. A., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316914 · Cited by 521

Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.

Rudolph, D., Yeh, W., Wakeham, A. C., Rudolph, B., Nallainathan, D., Potter, J., Elia, A., & Mak, T. W. (2000) · PubMed Central · Cited by 518

Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid Leukemia

Peeters, P. J., Raynaud, S., Cools, J., Włodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Rompaey, L. V., Baens, M., BERGHE, H. V. D., et al. (1997) · Blood · doi:10.1182/blood.v90.7.2535 · Cited by 489

Severe liver degeneration and lack of NF-κ B activation in NEMO/IKKγ-deficient mice

Rudolph, D., Yeh, W.-C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J., & Mak, T. W. (2000) · Genes & Development · doi:10.1101/gad.14.7.854 · Cited by 479

RET tyrosine kinase signaling in development and cancer.

Arighi, E., Borrello, M. G., & Sariola, H. (2005) · Cytokine & growth factor reviews · doi:10.1016/j.cytogfr.2005.05.010 · Cited by 476

Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes

Rutland, P., Pulleyn, L. J., Reardon, W., Baraitser, M., Hayward, R. D., Jones, B. M., Malcolm, S., Winter, R. M., Oldridge, M., Slaney, S. F., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-173 · Cited by 445

BMP Type II Receptor Is Required for Gastrulation and Early Development of Mouse Embryos

Beppu, H., Kawabata, M., Hamamoto, T., Chytil, A. M., Minowa, O., Noda, T., & Miyazono, K. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9670 · Cited by 420

A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle

Welch, P. J. (1993) · Cell · doi:10.1016/0092-8674(93)90497-e · Cited by 407

Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans

Meyers, G. A., Orlow, S. J., Munro, I. R., Przylepa, K. A., & Jabs, E. W. (1995) · Nature Genetics · doi:10.1038/ng1295-462 · Cited by 392

Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis

Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L. J. C., Jackson, S. J., Vottero, A., Kanabar, D. J., Charlton-Menys, V., Durrington, P. N., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 347

Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.

Petzer, A. L., Hogge, D. E., Landsdorp, P. M., Reid, D. S., & Eaves, C. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1470 · Cited by 346

Mutations that Cause Osteoglophonic Dysplasia Define Novel Roles for FGFR1 in Bone Elongation

White, K. E., Cabral, J. M., Davis, S. I., Fishburn, T., Evans, W., Ichikawa, S., Fields, J., Yu, X., Shaw, N. J., McLellan, N., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/427956 · Cited by 328

Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes

Bellus, G. A., Gaudenz, K., Zackai, E. H., Clarke, L. A., Szabo, J., Francomano, C. A., & Muenke, M. (1996) · Nature Genetics · doi:10.1038/ng1096-174 · Cited by 311

Endothelial apoptosis in Braf-deficient mice

Wojnowski, L., Zimmer, A. M., Beck, T. W., Hahn, H., Bernal, R. A., Rapp, U. R., & Zimmer, A. (1997) · Nature Genetics · doi:10.1038/ng0797-293 · Cited by 299

Whole-genome association study identifies STK39 as a hypertension susceptibility gene

Wang, Y., O'Connell, J. R., McArdle, P. F., Wade, J. B., Dorff, S. E., Shah, S. J., Shi, X., Pan, L., Rampersaud, E., Shen, H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808358106 · Cited by 298

The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2

Reiter, A., Walz, C., Watmore, A. E., Schoch, C., Blau, I., Schlegelberger, B., Berger, U., Telford, N., Aruliah, S., Yin, J. A. L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4263 · Cited by 269

Regulation and targets of receptor tyrosine kinases

Pawson, T. J. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80597-4 · Cited by 265

Structural and Functional Diversity of the Microbial Kinome

Kannan, N., Taylor, S. S., Zhai, Y., Venter, J. C., & Manning, G. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050017 · Cited by 265

The BCR gene encodes a novel serine/threonine kinase activity within a single exon

Maru, Y., & Witte, O. N. (1991) · Cell · doi:10.1016/0092-8674(91)90521-y · Cited by 262

Genome-wide identification of genes likely to be involved in human genetic disease

López-Bigas, N. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh605 · Cited by 260

Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism

Pitteloud, N., Acierno, J. S., Meysing, A., Eliseenkova, A. V., Ma, J., Ibrahimi, O. A., Metzger, D. L., Hayes, F. J., Dwyer, A. A., Hughes, V. A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600962103 · Cited by 242

Missense Mutations in the Regulatory Domain of PKCγ: A New Mechanism for Dominant Nonepisodic Cerebellar Ataxia

Chen, D.-H., Brkanac, Z., Verlinde, C. L. M. J., Tan, X.-J., Bylenok, L., Nochlin, D., Matsushita, M. M., Lipe, H., Wolff, J., Fernandez, M. J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/373883 · Cited by 238

The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module

Kannan, N., Haste, N. M., Taylor, S. S., & Neuwald, A. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610251104 · Cited by 236

Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation

Takeuchi, S., Takeda, K., Oishi, I., Nomi, M., Ikeya, M., Itoh, K., Tamura, S., Ueda, T., Hatta, T., Otani, H., et al. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00300.x · Cited by 224

Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism

Lynch, D. K., Ellis, C. A., Edwards, P. A., & Hiles, I. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203258 · Cited by 216

Genetics of Complex Disease

Schork, N. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.12-tac-5 · Cited by 202

The amino-acid mutational spectrum of human genetic disease

Vitkup, D., Sander, C., & Church, G. M. (2003) · Genome biology · doi:10.1186/gb-2003-4-11-r72 · Cited by 201

Renal Aplasia in Humans Is Associated with RET Mutations

Skinner, M. A., Safford, S. D., Reeves, J. G., Jackson, M. E., & Freemerman, A. J. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.008 · Cited by 197

Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers

Capra, M. C., Nuciforo, P. G., Confalonieri, S., Quarto, M., Bianchi, M., Nebuloni, M., Boldorini, R. L., Pallotti, F., Viale, G., Gishizky, M. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3489 · Cited by 196

Dissociating the dual roles of apoptosis‐inducing factor in maintaining mitochondrial structure and apoptosis

Cheung, E. C., Joza, N. A., Steenaart, N. A. E., McClellan, K. A., Neuspiel, M., McNamara, S., MacLaurin, J. G., Rippstein, P. U., Park, D. S., Shore, G. C., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601276 · Cited by 191

The nuclear serine/threonine protein kinase DNA-PK.

Anderson, C. W., & Lees‐Miller, S. P. (1992) · PubMed · Cited by 191

The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins

Demiroglu, A., Baxter, E. J., Heath, C., Taylor, K. M., Bentley, M. A., Allen, S. L., Koduru, P., BRODY, J. P., Hawson, G. A. T., Rodwell, R. L., et al. (2001) · Blood · doi:10.1182/blood.v98.13.3778 · Cited by 190

Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction.

Cheng, G., Ye, Z. S., & Baltimore, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8152 · Cited by 171

The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes

Sparsø, T., Andersen, G., Nielsen, T., Burgdorf, K. S., Gjesing, A. P., Nielsen, A. L., Albrechtsen, A., Rasmussen, S. S., Jørgensen, T., Borch‐Johnsen, K., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0865-z · Cited by 171

Mutations of thePRKAR1AGene in Cushing’s Syndrome due to Sporadic Primary Pigmented Nodular Adrenocortical Disease

Groussin, L., Jullian, E. H., Perlemoine, K., Louvel, A., Leheup, B., LUTON, J. P., BERTAGNA, X. Y., & Bertherat, J. Y. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020592 · Cited by 168

Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.

Eng, C., Crossey, P. A., Mulligan, L. M., Healey, C. S., Houghton, C. A., Prowse, A. H., Chew, S. L., Dahia, P. L. M., O'Riordan, J. L. H., & Toledo, S. P. A. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.934 · Cited by 167

Did Protein Kinase Regulatory Mechanisms Evolve Through Elaboration of a Simple Structural Component?

Kannan, N., & Neuwald, A. F. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.057 · Cited by 159

Variant between CPT1B and CHKB associated with susceptibility to narcolepsy

Miyagawa, T., Kawashima, M., Nishida, N., Ohashi, J., Kimura, R., Fujimoto, A., Shimada, M., Morishita, S., Shigeta, T., Lin, L., et al. (2008) · Nature Genetics · doi:10.1038/ng.231 · Cited by 152

WNK1 Activates ERK5 by an MEKK2/3-dependent Mechanism

Xu, B.-E., Stippec, S., Lenertz, L. Y., Lee, B., Zhang, W., Lee, Y.-K., & Cobb, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313465200 · Cited by 148

Primary Immunodeficiency Diseases: A Molecular and Genetic Approach

Holland, S. M., & Fleisher, T. A. (1999) · Clinical Immunology · doi:10.1006/clim.1999.4715 · Cited by 145

Mutations of the RET-GDNF Signaling Pathway in Ondine's Curse

Amiel, J., Salomon, R., Attié‐Bitach, T., Pelet, A., Trang, H., Mokhtari, M., Gaultier, C., Münnich, A., & Lyonnet, S. (1998) · The American Journal of Human Genetics · doi:10.1086/301759 · Cited by 117

Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma

Wright, T. M., Brannon, A. R., Gordan, J. D., Mikels, A. J., Mitchell, C., Chen, S., Espinosa, Í., van de Rijn, M., Pruthi, R. S., Wallen, E., et al. (2009) · Oncogene · doi:10.1038/onc.2009.116 · Cited by 116

Current concepts in RET-related genetics, signaling and therapeutics

Plaza-Menacho, I., Burzynski, G. M., de Groot, J. W. B., Eggen, B. J. L., & Hofstra, R. M. W. (2006) · Trends in Genetics · doi:10.1016/j.tig.2006.09.005 · Cited by 109

Bone Morphogenetic Protein Receptor Type II C-Terminus Interacts with c-Src

Wong, W. K. P., Knowles, J. A., & Morse, J. H. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0103oc · Cited by 104

JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival

Tefferi, A., Lasho, T. L., Patnaik, M. M., Finke, C. M., Hussein, K., Hogan, W. J., Elliott, M. A., Litzow, M. R., Hanson, C. A., & Pardanani, A. D. (2009) · Leukemia · doi:10.1038/leu.2009.225 · Cited by 104

Cancer driver mutations in protein kinase genes

Torkamani, A., Verkhivker, G. M., & Schork, N. J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.008 · Cited by 102

Prediction of Cancer Driver Mutations in Protein Kinases

Torkamani, A., & Schork, N. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5283 · Cited by 102

Roles of FGF signaling in skeletal development and human genetic diseases

Lin, C. (2005) · Frontiers in bioscience · doi:10.2741/1671 · Cited by 94

LMNA mutation position predicts organ system involvement in laminopathies

Hegele, R. A. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00447.x · Cited by 93

Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.

Pouliot, F., Blais, A., & Labrie, C. (2003) · PubMed · Cited by 82

Identification of Yin-Yang Regulators and a Phosphorylation Consensus for Male Germ Cell-Associated Kinase (MAK)-Related Kinase

Fu, Z., Larson, K. A., Chitta, R. K., Parker, S. A., Turk, B. E., Lawrence, M. W., Kaldis, P., Galaktionov, K. I., Cohn, S. M., Shabanowitz, J., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00816-06 · Cited by 80

MAPK regulation of gene expression in airway smooth muscle

Gerthoffer, W. T., & Singer, C. A. (2003) · Respiratory Physiology & Neurobiology · doi:10.1016/s1569-9048(03)00150-2 · Cited by 79

Scythe Regulates Apoptosis-inducing Factor Stability during Endoplasmic Reticulum Stress-induced Apoptosis

Desmots, F., Russell, H. R., Michel, D., & McKinnon, P. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706419200 · Cited by 75

Lethal Congenital Contractural Syndrome Type 2 (LCCS2) Is Caused by a Mutation in ERBB3 (Her3), a Modulator of the Phosphatidylinositol-3-Kinase/Akt Pathway

Narkis, G., Ofir, R., Manor, E., Landau, D., Elbedour, K., & Birk, O. S. (2007) · The American Journal of Human Genetics · doi:10.1086/520770 · Cited by 73

Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2

O’Donovan, M. C., Norton, N., Williams, H. J., Peirce, T., Moskvina, V., Nikolov, I., Hamshere, M. L., Carroll, L. S., Georgieva, L., Dwyer, S., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.108 · Cited by 72

A Multiplex Human Syndrome Implicates a Key Role for Intestinal Cell Kinase in Development of Central Nervous, Skeletal, and Endocrine Systems

Lahiry, P., Wang, J., Robinson, J. F., Turowec, J. P., Litchfield, D. W., Lanktree, M. B., Gloor, G. B., Puffenberger, E. G., Strauss, K. A., Martens, M. B., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.12.017 · Cited by 68

Congenital disease SNPs target lineage specific structural elements in protein kinases

Torkamani, A., Kannan, N., Taylor, S. S., & Schork, N. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802403105 · Cited by 65

Mutation analysis of the CHK2 gene in breast carcinoma and other cancers

Ingvarsson, S., Sigbjornsdottir, B. I., Huiping, C., Hafsteinsdottir, S. H., Ragnarsson, G., Barkardottir, R. B., Arason, A., Egilsson, V., & Bergthorsson, J. T. (2002) · Breast Cancer Research · doi:10.1186/bcr435 · Cited by 63

KinMutBase: A registry of disease-causing mutations in protein kinase domains

Ortutay, C., Väliaho, J., Stenberg, K., & Vihinen, M. (2005) · Human Mutation · doi:10.1002/humu.20166 · Cited by 63

Using Substrate-Binding Variants of the cAMP-Dependent Protein Kinase to Identify Novel Targets and a Kinase Domain Important for Substrate Interactions in Saccharomyces cerevisiae

Deminoff, S. J., Howard, S. C., Hester, A., Warner, S., & Herman, P. K. (2006) · Genetics · doi:10.1534/genetics.106.059238 · Cited by 61

The second wave in kinase cancer drugs

Garber, K. (2006) · Nature Biotechnology · doi:10.1038/nbt0206-127 · Cited by 58

Interplay Between the Gamma Isoform of PKC and Calcineurin in Regulation of Vulnerability to Focal Cerebral Ischemia

Aronowski, J. A., Grotta, J. C., Strong, R., & Waxham, M. N. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200002000-00016 · Cited by 53

Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests

Xue, F., Yu, H., Maurer, L. H., Memoll, V. A., Nutile‐McMenemy, N., Schuster, M. K., Bowden, D. W., Mao, J.-I., & Noll, W. W. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.4.635 · Cited by 53

Computational Modeling of Structurally Conserved Cancer Mutations in the RET and MET Kinases: The Impact on Protein Structure, Dynamics, and Stability

Dixit, A., Torkamani, A., Schork, N. J., & Verkhivker, G. M. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.10.041 · Cited by 48

FLT3 and its Role in the Pathogenesis of Acute Myeloid Leukaemia

Reilly, J. T. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000040233 · Cited by 45

What’s new in the neuro-cardio-facial-cutaneous syndromes?

Denayer, E., & Legius, E. (2007) · European Journal of Pediatrics · doi:10.1007/s00431-007-0535-7 · Cited by 38

Phenomics, Lipodystrophy, and the Metabolic Syndrome

Hegele, R. A. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.02.001 · Cited by 36

Altered neurodevelopment associated with mutations of RSK2: a morphometric MRI study of Coffin–Lowry syndrome

Kesler, S. R., Simensen, R. J., Voeller, K. K. S., Abidi, F., Stevenson, R. E., Schwartz, C. E., & Reiss, A. L. (2007) · Neurogenetics · doi:10.1007/s10048-007-0080-6 · Cited by 36

BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension

Sankelo, M., Flanagan, J. A., Machado, R. D., Harrison, R., Rudarakanchana, N., Morrell, N. W., Dixon, M., Halme, M. K., Puolijoki, H., Kere, J., et al. (2005) · Human Mutation · doi:10.1002/humu.20200 · Cited by 32

Molecular diagnosis of X-linked agammaglobulinaemia

Vorechkovsky, I., Zhou, J.-N., Vetrie, D. L. P., Bentley, D. R., Björkander, J., Hammarström, L. L. G., & Smith, C. I. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)93172-w · Cited by 32

AIP1: a new player in TNF signaling

Guicciardi, M. E., & Gores, G. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318911 · Cited by 30

Distribution analysis of nonsynonymous polymorphisms within the human kinase gene family

Torkamani, A., & Schork, N. J. (2007) · Genomics · doi:10.1016/j.ygeno.2007.03.006 · Cited by 29

AIP1: a new player in TNF signaling

Guicciardi, M. E., & Gores, G. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18911 · Cited by 29

Acanthosis Nigricans and Insulin Sensitivity in Patients with Achondroplasia and Hypochodroplasia due to FGFR3 Mutations

Alatzoglou, K. S., Hindmarsh, P. C., Brain, C. E., Torpiano, J. G., & Dattani, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0322 · Cited by 25

Ca2+/calmodulin-dependent protein kinase II in postsynaptic densities after reversible cerebral ischemia in rats

Aronowski, J. A., & Grotta, J. C. (1996) · Brain Research · doi:10.1016/0006-8993(95)01311-3 · Cited by 25

Integrated Strategy for Fast and Automated Molecular Characterization of Genes Involved in Craniosynostosis

Stenirri, S., Restagno, G., Ferrero, G. B., Alaimo, G., Sbaiz, L., Mari, C., Genitori, L., Maurizio, F., & Cremonesi, L. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.089292 · Cited by 20

Phenomics, Lamin A/C, and Metabolic Disease

Hegele, R. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2078 · Cited by 8

The prevention of breast cancer: Is genetics just diversionary?

Pike, M. C. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80001-6 · Cited by 6

Severe Combined Immunodeficiency Due to Defects in T Cell Receptor–Associated Protein Tyrosine Kinases

Elder, M. E. (2006) · doi:10.1093/oso/9780195147742.003.0014 · Cited by 1

Angiogenic signaling pathways and anti-angiogenic therapy for cancer

Liu, Z., Chen, H., Zheng, L., Sun, L., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,486

Mechanisms of receptor tyrosine kinase activation in cancer

Du, Z., & Lovly, C. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0782-4 · Cited by 1,066

Trends in kinase drug discovery: targets, indications and inhibitor design

Attwood, M. M., Fabbro, D., Sokolov, A. V., Knapp, S., & Schiöth, H. B. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00252-y · Cited by 850

An atlas of substrate specificities for the human serine/threonine kinome

Johnson, J. L., Yaron, T. M., Huntsman, E. M., Kerelsky, A., Song, J., Regev, A., Lin, T.-Y., Liberatore, K., Cizin, D. M., Cohen, B. M., et al. (2023) · Nature · doi:10.1038/s41586-022-05575-3 · Cited by 728

The potential health effects of dietary phytoestrogens

Rietjens, I. M. C. M., Louisse, J., & Beekmann, K. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13622 · Cited by 512

Mutations in the protein kinase superfamily

Izarzugaza, G., & José, M. (2011) · Dialnet (Universidad de la Rioja)

RESEARCH Open Access Characterization of pathogenic germline mutations in human Protein Kinases

Izarzugaza, J. M. G., Hopcroft, L. E., Barešić, A., Orengo, C. A., Martin, A. C. R., & Valencia, A. (2010)

KinMutBase: A registry of disease-causing mutations in protein kinase domains

Ortutay, C., Väliaho, J., Stenberg, K., & Vihinen, M. (2005) · Human Mutation · doi:10.1002/humu.20166 · Cited by 63

Characterization of pathogenic germline mutations in human Protein Kinases

Izarzugaza, J. M. G., Hopcroft, L. E. M., Barešić, A., Orengo, C. A., Martin, A. C. R., & Valencia, A. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-s4-s1 · Cited by 20

KinMutBase, a database of human disease-causing protein kinase mutations

Stenberg, K. A. E., Riikonen, P., & Vihinen, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.362 · Cited by 38